Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meike Scharenberg

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Medicinal Chemistry|October 24, 2012
Target Selectivity of FimH AntagonistsMeike Scharenberg, Oliver Schwardt, Said Rabbani, et al.
Cellular and Molecular Life Sciences : CMLS|May 21, 2011
"Add-on" domains of Drosophila β1,4-N-acetylgalactosaminyltransferase B in the stem region and its pilot proteinBenjamin Kraft, Anita Johswich, Gwenda Kauczor, et al.
Assay and Drug Development Technologies|June 17, 2011
A flow cytometry-based assay for screening FimH antagonistsMeike Scharenberg, Daniela Abgottspon, Evelin Cicek, et al.
Chemmedchem|December 21, 2013
Kinetic properties of carbohydrate-lectin interactions: FimH antagonistsMeike Scharenberg, Xiaohua Jiang, Lijuan Pang, et al.
Journal of Medicinal Chemistry|April 24, 2012
Antiadhesion therapy for urinary tract infections--a balanced PK/PD profile proved to be key for successXiaohua Jiang, Daniela Abgottspon, Simon Kleeb, et al.
Chemmedchem|May 31, 2012
FimH antagonists: structure-activity and structure-property relationships for biphenyl α-D-mannopyranosidesLijuan Pang, Simon Kleeb, Katrin Lemme, et al.
Chembiochem : a European Journal of Chemical Biology|March 19, 2016
The Conformational Variability of FimH: Which Conformation Represents the Therapeutic Target?Deniz Eris, Roland C Preston, Meike Scharenberg, et al.
Immunity|March 3, 2019
Human Memory B Cells Harbor Diverse Cross-Neutralizing Antibodies against BK and JC PolyomavirusesJohn M Lindner, Vanessa Cornacchione, Atul Sathe, et al.
Journal of Medicinal Chemistry|November 26, 2010
FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to in vitro and in vivo evaluationTobias Klein, Daniela Abgottspon, Matthias Wittwer, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2017
Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophyFrederic Morvan, Jean-Michel Rondeau, Chao Zou, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Medicinal Chemistry|October 24, 2012
Target Selectivity of FimH AntagonistsMeike Scharenberg, Oliver Schwardt, Said Rabbani, et al.
Cellular and Molecular Life Sciences : CMLS|May 21, 2011
"Add-on" domains of Drosophila β1,4-N-acetylgalactosaminyltransferase B in the stem region and its pilot proteinBenjamin Kraft, Anita Johswich, Gwenda Kauczor, et al.
Assay and Drug Development Technologies|June 17, 2011
A flow cytometry-based assay for screening FimH antagonistsMeike Scharenberg, Daniela Abgottspon, Evelin Cicek, et al.
Chemmedchem|December 21, 2013
Kinetic properties of carbohydrate-lectin interactions: FimH antagonistsMeike Scharenberg, Xiaohua Jiang, Lijuan Pang, et al.
Journal of Medicinal Chemistry|April 24, 2012
Antiadhesion therapy for urinary tract infections--a balanced PK/PD profile proved to be key for successXiaohua Jiang, Daniela Abgottspon, Simon Kleeb, et al.
Chemmedchem|May 31, 2012
FimH antagonists: structure-activity and structure-property relationships for biphenyl α-D-mannopyranosidesLijuan Pang, Simon Kleeb, Katrin Lemme, et al.
Chembiochem : a European Journal of Chemical Biology|March 19, 2016
The Conformational Variability of FimH: Which Conformation Represents the Therapeutic Target?Deniz Eris, Roland C Preston, Meike Scharenberg, et al.
Immunity|March 3, 2019
Human Memory B Cells Harbor Diverse Cross-Neutralizing Antibodies against BK and JC PolyomavirusesJohn M Lindner, Vanessa Cornacchione, Atul Sathe, et al.
Journal of Medicinal Chemistry|November 26, 2010
FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to in vitro and in vivo evaluationTobias Klein, Daniela Abgottspon, Matthias Wittwer, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2017
Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophyFrederic Morvan, Jean-Michel Rondeau, Chao Zou, et al.
Pageof 2